WHO ICTRP trial
Single-agent Panitumumab in the frail patients with wild-type RAS unresectable…
JPRN-jRCTs051180108 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTs051180108 |
|---|---|
| Public title | Single-agent Panitumumab in the frail patients with wild-type RAS unresectable colorectal cancer |
| Scientific title | First-line single-agent Panitumumab in the frail patients with wild-type RAS unresectable colorectal cancer: A phase II study - OGSG 1602 |
| Primary sponsor | GOTO Masahiro |
| Secondary sponsors | Osaka Clinical Study Supporting Organization |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Colorectal Cancer Colorectal Cancer;C18-20;Colorectal Cancer |
| Interventions | Panitumumab(6mg/Kg day1) therapy every two weeks |
| Registration date | Aug 3, 2019 |
| Target size | 36 |
| Secondary IDs | UMIN000024528 |
| Registry page | jrct.niph.go.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: